Advertising regulation

From Ganfyd

Advertising regulation is widespread in healthcare. Health practitioners often have defined limitations to professional advertising through regulation and their professional associations. Advertising standards for drugs with marketing authorisation are usually regulated to higher standards than in other industries both by voluntary self regulation and legislation.

• The False Claims Act 1863
  • Merck & Co agreed a settlement for $950 million over promotion and marketing of rofecoxib in 2011^[1].
  • GlaxoSmithKline agreed a settlement relating to several products, mainly associated with rosiglitazone, of about $3 billion in 2011^[2]
  • Pfizer agreed a settlement of $2.3 billion in 2009 for illegally marketing four drugs^[3]

Regulated by:

• Advertising Standards Authority
• Association of the British Pharmaceutical Industry
• MHRA

References